Intellectual Property India Publishes Patent Application for 'Cytotoxic Imidazo[1,2-A]pyridine Compounds And Their Use In Therapy' Filed by Myricx Pharma Limited; and Imperial College Innovations Limited

MUMBAI, India, April 25 -- Intellectual Property India has published a patent application (202517033093 A) filed by Myricx Pharma Limited; and Imperial College Innovations Limited, London, U.K., on April 3, for 'cytotoxic imidazo[1,2-a]pyridine compounds and their use in therapy.'

Inventor(s) include Carr, Robin; Solari, Roberto; Bell, Andrew Simon; Tate, Edward William; and Bonnert, Roger.

The application for the patent was published on April 25, under issue no. 17/2025.

According to the abstract released by the Intellectual Property India: "The present invention relates to compounds of formula (I) and related aspects."

The patent application was internationally filed on Sept. 08, 2023, under International application No.PCT/GB2023/052...